These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25406035)

  • 1. Effects of sevoflurane on leucine-rich repeat kinase 2-associated Drosophila model of Parkinson's disease.
    Shan Z; Cai S; Zhang T; Kuang L; Wang Q; Xiu H; Wen J; Gu H; Xu K
    Mol Med Rep; 2015 Mar; 11(3):2062-70. PubMed ID: 25406035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a Parkinson's disease mutant of Leucine-Rich Repeat Kinase 2 (LRRK2).
    Linhart R; Wong SA; Cao J; Tran M; Huynh A; Ardrey C; Park JM; Hsu C; Taha S; Peterson R; Shea S; Kurian J; Venderova K
    Mol Neurodegener; 2014 Jun; 9():23. PubMed ID: 24915984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leucine-Rich Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease.
    Venderova K; Kabbach G; Abdel-Messih E; Zhang Y; Parks RJ; Imai Y; Gehrke S; Ngsee J; Lavoie MJ; Slack RS; Rao Y; Zhang Z; Lu B; Haque ME; Park DS
    Hum Mol Genet; 2009 Nov; 18(22):4390-404. PubMed ID: 19692353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis.
    Zhou ZD; Saw WT; Ho PGH; Zhang ZW; Zeng L; Chang YY; Sun AXY; Ma DR; Wang HY; Zhou L; Lim KL; Tan EK
    Cell Mol Life Sci; 2022 Nov; 79(12):599. PubMed ID: 36409355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis.
    Matta S; Van Kolen K; da Cunha R; van den Bogaart G; Mandemakers W; Miskiewicz K; De Bock PJ; Morais VA; Vilain S; Haddad D; Delbroek L; Swerts J; Chávez-Gutiérrez L; Esposito G; Daneels G; Karran E; Holt M; Gevaert K; Moechars DW; De Strooper B; Verstreken P
    Neuron; 2012 Sep; 75(6):1008-21. PubMed ID: 22998870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synaptic function of LRRK2.
    Lee S; Imai Y; Gehrke S; Liu S; Lu B
    Biochem Soc Trans; 2012 Oct; 40(5):1047-51. PubMed ID: 22988863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Drosophila hep pathway mediates Lrrk2-induced neurodegeneration.
    Yang D; Thomas JM; Li T; Lee Y; Liu Z; Smith WW
    Biochem Cell Biol; 2018 Aug; 96(4):441-449. PubMed ID: 29268033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting thrombin improves motor function and decreases oxidative stress in the LRRK2 transgenic Drosophila melanogaster model of Parkinson's disease.
    Johnson SL; Iannucci J; Seeram NP; Grammas P
    Biochem Biophys Res Commun; 2020 Jun; 527(2):532-538. PubMed ID: 32423817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mouse/human cross-species heterodimer of leucine-rich repeat kinase 2: possible significance in the transgenic model mouse of Parkinson's disease.
    Miyajima T; Ohta E; Kawada H; Maekawa T; Obata F
    Neurosci Lett; 2015 Feb; 588():142-6. PubMed ID: 25562633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and Morphological Correlates in the Drosophila LRRK2 loss-of-function Model of Parkinson's Disease: Drug Effects of Withania somnifera (Dunal) Administration.
    De Rose F; Marotta R; Poddighe S; Talani G; Catelani T; Setzu MD; Solla P; Marrosu F; Sanna E; Kasture S; Acquas E; Liscia A
    PLoS One; 2016; 11(1):e0146140. PubMed ID: 26727265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic synaptic transmissions were altered after single sevoflurane exposure in Drosophila pupa.
    Chen R; Zhang T; Kuang L; Chen Z; Ran D; Niu Y; Xu K; Gu H
    Biomed Res Int; 2015; 2015():485709. PubMed ID: 25705662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human R1441C LRRK2 regulates the synaptic vesicle proteome and phosphoproteome in a Drosophila model of Parkinson's disease.
    Islam MS; Nolte H; Jacob W; Ziegler AB; Pütz S; Grosjean Y; Szczepanowska K; Trifunovic A; Braun T; Heumann H; Heumann R; Hovemann B; Moore DJ; Krüger M
    Hum Mol Genet; 2016 Dec; 25(24):5365-5382. PubMed ID: 27794539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of LRRK2/PARK8 induces degeneration of dopaminergic neurons in Drosophila.
    Lee SB; Kim W; Lee S; Chung J
    Biochem Biophys Res Commun; 2007 Jun; 358(2):534-9. PubMed ID: 17498648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abberant protein synthesis in G2019S LRRK2 Drosophila Parkinson disease-related phenotypes.
    Martin I; Abalde-Atristain L; Kim JW; Dawson TM; Dawson VL
    Fly (Austin); 2014; 8(3):165-9. PubMed ID: 25483009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vps35 in cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in Drosophila.
    Inoshita T; Arano T; Hosaka Y; Meng H; Umezaki Y; Kosugi S; Morimoto T; Koike M; Chang HY; Imai Y; Hattori N
    Hum Mol Genet; 2017 Aug; 26(15):2933-2948. PubMed ID: 28482024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral deficits and striatal DA signaling in LRRK2 p.G2019S transgenic rats: a multimodal investigation including PET neuroimaging.
    Walker MD; Volta M; Cataldi S; Dinelle K; Beccano-Kelly D; Munsie L; Kornelsen R; Mah C; Chou P; Co K; Khinda J; Mroczek M; Bergeron S; Yu K; Cao LP; Funk N; Ott T; Galter D; Riess O; Biskup S; Milnerwood AJ; Stoessl AJ; Farrer MJ; Sossi V
    J Parkinsons Dis; 2014; 4(3):483-98. PubMed ID: 25000966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila.
    Angeles DC; Ho P; Chua LL; Wang C; Yap YW; Ng C; Zhou Zd; Lim KL; Wszolek ZK; Wang HY; Tan EK
    Hum Mol Genet; 2014 Jun; 23(12):3157-65. PubMed ID: 24459295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse models for LRRK2 Parkinson's disease.
    Xu Q; Shenoy S; Li C
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S186-9. PubMed ID: 22166430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease.
    Yescas P; López M; Monroy N; Boll MC; Rodríguez-Violante M; Rodríguez U; Ochoa A; Alonso ME
    Neurosci Lett; 2010 Nov; 485(2):79-82. PubMed ID: 20727385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2 kinase activity mediates toxic interactions between genetic mutation and oxidative stress in a Drosophila model: suppression by curcumin.
    Yang D; Li T; Liu Z; Arbez N; Yan J; Moran TH; Ross CA; Smith WW
    Neurobiol Dis; 2012 Sep; 47(3):385-92. PubMed ID: 22668778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.